Gender difference in the association of insulin and the insulin-like growth factor axis with colorectal neoplasia

International Journal of Obesity

Volumn 36, Issue 3, 2012, Pages 440-447

  Yamaji, T ^a   Iwasaki, M ^a   Sasazuki, S ^a   Tsugane, S ^a  

^a NATIONAL CANCER CENTER   (Japan)

Author keywords

case control studies; colorectal adenoma; insulin; insulin like growth factor; insulin like growth factor binding protein

Indexed keywords

C PEPTIDE; INSULIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; CARCINOGENESIS; COLONOSCOPY; COLORECTAL ADENOMA; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE;

ADENOMA; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; C-PEPTIDE; CASE-CONTROL STUDIES; CELL TRANSFORMATION, NEOPLASTIC; COLONOSCOPY; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR I; LIFE STYLE; LOGISTIC MODELS; MALE; MIDDLE AGED; OBESITY; ODDS RATIO; QUESTIONNAIRES; RISK FACTORS; SEX DISTRIBUTION; SEX FACTORS;

EID: 84858290562     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2011.114     Document Type: Article

References (28)

1. World Health Organization. GLOBOCAN 2008: Cancer Incidence and Mortality Worldwide in 2008. World Health Organization: Geneva, Switzerland. (http://globocan.iarc.fr/) (Accessed February 1, 2011).
2. World Health Organization. Global Database on Body Mass Index. World Health Organization: Geneva, Switzerland. (http://apps.who.int/bmi/index.jsp ) (Accessed February 1, 2011).
3. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Bodymass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008; 371: 569-578. (Pubitemid 351232031)
4. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004; 4: 579-591. (Pubitemid 39025053)
5. Renehan AG, Frystyk J, Flyvbjerg A. Obesity and cancer risk: the role of the insulin-IGF axis. Trends Endocrinol Metab 2006; 17: 328-336. (Pubitemid 44397568)
6. Giovannucci E, Michaud D. The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology 2007; 132: 2208-2225. (Pubitemid 46693749)
7. Tsugane S, Inoue M. Insulin resistance and cancer: epidemiological evidence. Cancer Sci 2010; 101: 1073-1079.
8. Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006; 444: 881-887. (Pubitemid 46024995)
9. Otani T, Iwasaki M, Sasazuki S, Inoue M, Tsugane S. Plasma C-peptide, insulin-like growth factor-I, insulin-like growth factor binding proteins and risk of colorectal cancer in a nested casecontrol study: the Japan public health center-based prospective study. Int J Cancer 2007; 120: 2007-2012. (Pubitemid 46418381)
10. Keku TO, Lund PK, Galanko J, Simmons JG, Woosley JT, Sandler RS. Insulin resistance, apoptosis, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 2005; 14: 2076-2081. (Pubitemid 41603248)
11. Yamaji T, Iwasaki M, Sasazuki S, Kurahashi N, Mutoh M, Yamamoto S et al. Visceral fat volume and the prevalence of colorectal adenoma. Am J Epidemiol 2009; 170: 1502-1511.
12. Yamaji T, Iwasaki M, Sasazuki S, Sakamoto H, Yoshida T, Tsugane S. Methionine synthase A2756G polymorphism interacts with alcohol and folate intake to influence the risk of colorectal adenoma. Cancer Epidemiol Biomarkers Prev 2009; 18: 267-274.
13. Yamaji T, Iwasaki M, Sasazuki S, Tsugane S. Interaction between adiponectin and leptin influences the risk of colorectal adenoma. Cancer Res 2010; 70: 5430-5437.
14. Kudo S, Hirota S, Nakajima T, Hosobe S, Kusaka H, Kobayashi T et al. Colorectal tumours and pit pattern. J Clin Pathol 1994; 47: 880-885.
15. Resources Council, Science and Technology Agency. Standard Tables of Food Composition in Japan, 5th Revised edn. Printing Office, the Ministry of Finance: Tokyo, Japan, 2000.
16. Giovannucci E, Pollak MN, Platz EA, Willett WC, Stampfer MJ, Majeed N et al. A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women. Cancer Epidemiol Biomarkers Prev 2000; 9: 345-349. (Pubitemid 30265776)
17. Renehan AG, Painter JE, Atkin WS, Potten CS, Shalet SM, O'Dwyer ST. High-risk colorectal adenomas and serum insulinlike growth factors. Br J Surg 2001; 88: 107-113. (Pubitemid 32066068)
18. Nishii T, Kono S, Abe H, Eguchi H, Shimazaki K, Hatano B et al. Glucose intolerance, plasma insulin levels, and colon adenomas in Japanese men. Jpn J Cancer Res 2001; 92: 836-840. (Pubitemid 32894092)
19. Teramukai S, Rohan T, Lee KY, Eguchi H, Oda T, Kono S. Insulinlike growth factor (IGF)-I, IGF-binding protein-3 and colorectal adenomas in Japanese men. Jpn J Cancer Res 2002; 93: 1187-1194. (Pubitemid 36032980)
20. Schoen RE, Weissfeld JL, Kuller LH, Thaete FL, Evans RW, Hayes RB et al. Insulin-like growth factor-I and insulin are associated with the presence and advancement of adenomatous polyps. Gastroenterology 2005; 129: 464-475. (Pubitemid 41096634)
21. Wei EK, Ma J, Pollak MN, Rifai N, Fuchs CS, Hankinson SE et al. C-peptide, insulin-like growth factor binding protein-1, glycosylated hemoglobin, and the risk of distal colorectal adenoma in women. Cancer Epidemiol Biomarkers Prev 2006; 15: 750-755.
22. Yoshida I, Suzuki A, Vallee M, Matano Y, Masunaga T, Zenda T et al. Serum insulin levels and the prevalence of adenomatous and hyperplastic polyps in the proximal colon. Clin Gastroenterol Hepatol 2006; 4: 1225-1231. (Pubitemid 44512215)
23. Tsilidis KK, Brancati FL, Pollak MN, Rifai N, Clipp SL, Hoffman-Bolton J et al. Metabolic syndrome components and colorectal adenoma in the CLUE II cohort. Cancer Causes Control 2010; 21: 1-10.
24. Yamamoto S, Nakagawa T, Matsushita Y, Kusano S, Hayashi T, IrokawaMet al. Visceral fat area andmarkers of insulin resistance in relation to colorectal neoplasia. Diabetes Care 2010; 33: 184-189.
25. Pisani P. Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies. Arch Physiol Biochem 2008; 114: 63-70. (Pubitemid 351998745)
26. Wheatcroft SB, Kearney MT. IGF-dependent and IGF-independent actions of IGF-binding protein-1 and-2: implications for metabolic homeostasis. Trends Endocrinol Metab 2009; 20: 153-162.
27. Calle EE, Miracle-McMahill HL, Thun MJ, Heath Jr CW. Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women. J Natl Cancer Inst 1995; 87: 517-523.
28. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321-333. (Pubitemid 34761611)